Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Women's Health

  • You have access
    Emerging blood-based biomarkers for Alzheimer disease
    Lynn M. Bekris, PhD and James B. Leverenz, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 537-539; DOI: https://doi.org/10.3949/ccjm.87a.20133

    A blood test for Alzheimer disease could help in drug development and patient care.

  • You have access
    Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
    Suneela Vegunta, MD and Margaret E. Long, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 541-544; DOI: https://doi.org/10.3949/ccjm.87a.19145

    Yes. Lacking guidelines, close surveillance is prudent.

  • You have access
    The HPV vaccine: Understanding and addressing barriers to vaccination
    Pelin Batur, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 545-548; DOI: https://doi.org/10.3949/ccjm.87a.20082

    Key steps include optimizing clinician-patient communication.

  • You have access
    In Reply: Perinatal depression
    Maureen Sayres Van Niel, MD and Jennifer L. Payne, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 456-457; DOI: https://doi.org/10.3949/ccjm.87c.08002
  • You have access
    Perinatal depression
    Elise Laflamme, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 456; DOI: https://doi.org/10.3949/ccjm.87c.08001
  • You have access
    DXA after menopause
    Michael Balkin, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 457; DOI: https://doi.org/10.3949/ccjm.87c.08003
  • You have access
    In Reply: DXA after menopause
    Kristi Tough DeSapri, MD and Rachel Brook, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 457-458; DOI: https://doi.org/10.3949/ccjm.87c.08004
  • You have access
    Liposuction: Concepts, safety, and techniques in body-contouring surgery
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 476;
  • You have access
    Irritable bowel syndrome with diarrhea: Treatment is a work in progress
    Michael Kurin, MD and Gregory Cooper, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 501-511; DOI: https://doi.org/10.3949/ccjm.87a.19011

    Understanding of its mechanisms is progressing, and treatments are increasingly targeted to the individual etiology.

  • You have access
    Glucocorticoid-induced osteoporosis: Insights for the clinician
    Shakaib Hayat, MD and Marina N. Magrey, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 417-426; DOI: https://doi.org/10.3949/ccjm.87a.19039

    Glucocorticoids cause significant bone loss, predominantly affecting trabecular bone, with consequent fragility fractures.

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 20
  • Adolescent Medicine
  • Allergy/Immunology
  • Anticoagulation
  • Cardiology
  • Covid-19
  • Critical Care
  • Dermatology
  • Diabetes
  • Drug Therapy
  • Electrophysiology
  • Emergency Medicine
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • Genetics
  • Geriatrics
  • Hematology
  • Hepatology
  • Hospice & Palliative Medicine
  • Hospital Medicine
  • Imaging
  • Infectious Diseases
  • Medical Humanities
  • Medical Humanities/Ethics
  • Men's Health
  • Mental Health
  • Nephrology
  • Neurology
  • Obesity
  • Oncology
  • Pain
  • Physical Exam
  • Practice Management
  • Preventive Care
  • Pulmonology
  • Rehabilitation Medicine
  • Rheumatology
  • Sleep Medicine
  • Surgery/Surgery Subspecialties
  • Vascular Medicine
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire